227 related articles for article (PubMed ID: 16207477)
21. Functional epigenomics identifies genes frequently silenced in prostate cancer.
Lodygin D; Epanchintsev A; Menssen A; Diebold J; Hermeking H
Cancer Res; 2005 May; 65(10):4218-27. PubMed ID: 15899813
[TBL] [Abstract][Full Text] [Related]
22. Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.
Schulz WA; Alexa A; Jung V; Hader C; Hoffmann MJ; Yamanaka M; Fritzsche S; Wlazlinski A; Müller M; Lengauer T; Engers R; Florl AR; Wullich B; Rahnenführer J
Mol Cancer; 2007 Feb; 6():14. PubMed ID: 17280610
[TBL] [Abstract][Full Text] [Related]
23. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
Lin HY; Kuo YC; Weng YI; Lai IL; Huang TH; Lin SP; Niu DM; Chen CS
Prostate; 2012 Dec; 72(16):1767-78. PubMed ID: 22539223
[TBL] [Abstract][Full Text] [Related]
24. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
25. Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo.
Pakneshan P; Xing RH; Rabbani SA
FASEB J; 2003 Jun; 17(9):1081-8. PubMed ID: 12773490
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men.
Devaney JM; Wang S; Furbert-Harris P; Apprey V; Ittmann M; Wang BD; Olender J; Lee NH; Kwabi-Addo B
Epigenetics; 2015; 10(4):319-28. PubMed ID: 25864488
[TBL] [Abstract][Full Text] [Related]
27. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
28. Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer.
Chin SP; Marthick JR; West AC; Short AK; Chuckowree J; Polanowski AM; Thomson RJ; Holloway AF; Dickinson JL
Prostate; 2015 May; 75(7):723-34. PubMed ID: 25662931
[TBL] [Abstract][Full Text] [Related]
29. S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors.
Rehman I; Cross SS; Azzouzi AR; Catto JW; Deloulme JC; Larre S; Champigneuille J; Fromont G; Cussenot O; Hamdy FC
Br J Cancer; 2004 Aug; 91(4):739-44. PubMed ID: 15280928
[TBL] [Abstract][Full Text] [Related]
30. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer.
Jarrard DF; Bova GS; Ewing CM; Pin SS; Nguyen SH; Baylin SB; Cairns P; Sidransky D; Herman JG; Isaacs WB
Genes Chromosomes Cancer; 1997 Jun; 19(2):90-6. PubMed ID: 9171999
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation regulates the expression of Y chromosome specific genes in prostate cancer.
Dasari VK; Deng D; Perinchery G; Yeh CC; Dahiya R
J Urol; 2002 Jan; 167(1):335-8. PubMed ID: 11743352
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.
Devaney JM; Wang S; Funda S; Long J; Taghipour DJ; Tbaishat R; Furbert-Harris P; Ittmann M; Kwabi-Addo B
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):292-300. PubMed ID: 23896626
[TBL] [Abstract][Full Text] [Related]
33. p21WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation.
Bott SR; Arya M; Kirby RS; Williamson M
Prostate Cancer Prostatic Dis; 2005; 8(4):321-6. PubMed ID: 16276353
[TBL] [Abstract][Full Text] [Related]
34. Methylation and mutational analysis of p27(kip1) in prostate carcinoma.
Kibel AS; Christopher M; Faith DA; Bova GS; Goodfellow PJ; Isaacs WB
Prostate; 2001 Sep; 48(4):248-53. PubMed ID: 11536304
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter methylation.
Ahmed H; Banerjee PP; Vasta GR
Biochem Biophys Res Commun; 2007 Jun; 358(1):241-6. PubMed ID: 17481580
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of d-glucuronyl C5-epimerase expression and epigenetic regulation in prostate cancer.
Prudnikova TY; Soulitzis N; Kutsenko OS; Mostovich LA; Haraldson K; Ernberg I; Kashuba VI; Spandidos DA; Zabarovsky ER; Grigorieva EV
Cancer Med; 2013 Oct; 2(5):654-61. PubMed ID: 24403231
[TBL] [Abstract][Full Text] [Related]
37. Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR.
Shah JN; Shao G; Hei TK; Zhao Y
BMC Cancer; 2008 Oct; 8():284. PubMed ID: 18834524
[TBL] [Abstract][Full Text] [Related]
38. EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling.
Kim YJ; Yoon HY; Kim SK; Kim YW; Kim EJ; Kim IY; Kim WJ
Clin Cancer Res; 2011 Jul; 17(13):4523-30. PubMed ID: 21571867
[TBL] [Abstract][Full Text] [Related]
39. Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer--novel predictor of biochemical recurrence after radical surgery.
Mitsui Y; Shiina H; Hiraki M; Arichi N; Hiraoka T; Sumura M; Honda S; Yasumoto H; Igawa M
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):487-96. PubMed ID: 22246902
[TBL] [Abstract][Full Text] [Related]
40. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]